XOMA ROYALTY

Trademark usage description

financial services, namely, financing related to intellectual property portfolios; financial services, namely, financing of pharmaceutical, drug, and Read More

Classification Information

Class [036]
Financial services, namely, financing related to intellectual property portfolios; financial services, namely, financing of pharmaceutical, drug, and medical device development; financial services, namely, providing capital to others by monetizing royalty streams and acquiring revenue interests relating to the sale of products; financial services, namely, funding through debt-like structures, the development and commercialization of products; financial services, namely, providing non-dilutive capital to counterparties, including through the purchase of revenue interests and the use of debt-like structures; equity capital investment.

Classification kind code

Class [042]
Pharmaceutical research and development.

Classification kind code

Class [045]
Licensing of intellectual property; licensing of pharmaceutical, biopharmaceutical, medicine, and chemical products and technology.

Classification kind code

Mark Details

Serial Number

2335094

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 257 on 27^th Jun 2024	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 27^th Jun 2024	Created
Submitted for opposition 31 on 27^th Jun 2024	Formalized
Submitted for opposition 30 on 2^th Apr 2024	Filed
Submitted for opposition 228 on 2^th Apr 2024	International Registration

XOMA ROYALTY

Classification Information

Classification kind code

Class [042]Pharmaceutical research and development.

Classification kind code

Class [045]Licensing of intellectual property; licensing of pharmaceutical, biopharmaceutical, medicine, and chemical products and technology.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Pharmaceutical research and development.

Class [045]
Licensing of intellectual property; licensing of pharmaceutical, biopharmaceutical, medicine, and chemical products and technology.